GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Fidaxomicin (Dificid)

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

DIFICID - adult oral C. difficile regimen

Product / population
Adults; named product and route only. Selected dosing and renal summary, not the full prescribing information.
Renal method
No renal-function dose bands specified for this summary.
Source revision
DailyMed updated 2024-10-16.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
Official

DIFICID - adult oral C. difficile regimen

Open original reference

NIH/NLM DailyMed - U.S. product labeling · Adults; named product and route only. Selected dosing and renal summary, not the full prescribing information.

Renal method: No renal-function dose bands specified for this summary.
Source date: DailyMed updated 2024-10-16.
Retrieved: 2026-09-05

Locally included source-specific summary. Regimen differences are not automatically resolved.

Dosing / renal protocol and limits

Adult C. difficile-associated diarrhea: 200 mg orally twice daily for 10 days, with or without food. No dose adjustment is recommended based on renal function, including the severe-impairment category studied (CrCl <=30 mL/min). The label does not provide a distinct dialysis replacement dose.

This is an oral intestinal-infection regimen, not treatment of systemic infection. Do not substitute the pediatric suspension volume table without confirming age, weight and concentration.

RDM30-074-fidaxomicin-1 · Source locator: DIFICID - adult oral C. difficile regimen; renal/dosing sections and stated qualifiers

Source identity and provenance
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd966338-c820-4270-b704-09ef75fa3ceb
Retrieved
2026-09-05
DailyMed Set ID
dd966338-c820-4270-b704-09ef75fa3ceb
Renal-function method
No renal-function dose bands specified for this summary.
Source date/version
DailyMed updated 2024-10-16.
Hash meaning
Locally authored summary text; not original SPL, HTML or PDF bytes
Local summary SHA-256
60e1804dd4a81741e3cb45c08921a6dcbc8d61b0b0f4b6a61f0c1cd34f24dc45

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=fidaxomicin&s1=RDM30-074-fidaxomicin&h1=b66ea19a52dfe663207f31ea62df26931d24541a1b5aed39e5be1f0994693797